loadpatents
Patent applications and USPTO patent grants for Mary; Caroline.The latest application filed is for "anti-sirpa antibodies and their therapeutic applications".
Patent | Date |
---|---|
Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody Grant 11,440,964 - Poirier , et al. September 13, 2 | 2022-09-13 |
ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS App 20220281991 - POIRIER; Nicolas ;   et al. | 2022-09-08 |
USES OF ANTI-SIRPg ANTIBODIES App 20220242951 - POIRIER; NICOLAS ;   et al. | 2022-08-04 |
Humanized anti-human-PD-1 antibody and its use in cancer treatment Grant 11,352,430 - Poirier , et al. June 7, 2 | 2022-06-07 |
Anti-SIRPa antibodies and their therapeutic applications Grant 11,279,766 - Poirier , et al. March 22, 2 | 2022-03-22 |
Bifunctional Anti-pd-1/sirpa Molecule App 20220056135 - POIRIER; NICOLAS ;   et al. | 2022-02-24 |
Bifunctional Molecule Directed Against Human Pd-1 App 20220025050 - POIRIER; NICOLAS ;   et al. | 2022-01-27 |
Non-antagonistic antibodies directed against the alpha chain of the IL7 receptor extracellular domain and use thereof in cancer treatment Grant 11,230,602 - Poirier , et al. January 25, 2 | 2022-01-25 |
Antibodies And Polypeptides Directed Against Cd127 App 20210395376 - POIRIER; Nicolas ;   et al. | 2021-12-23 |
Humanized Anti-human-pd-1 Antibody App 20210355225 - POIRIER; NICOLAS ;   et al. | 2021-11-18 |
Antibodies and polypeptides directed against CD127 Grant 11,098,128 - Poirier , et al. August 24, 2 | 2021-08-24 |
Modified Anti-sirpa Antibodies And Uses Thereof App 20210179728 - POIRIER; Nicolas ;   et al. | 2021-06-17 |
Anti-chemokin Like Receptor 1 Antibodies And Their Therapeutic Applications App 20210147558 - POIRIER; NICOLAS ;   et al. | 2021-05-20 |
Use Of Anti-human Sirpa V1 Antibodies And Method For Producing Anti-sirpa V1 Antibodies App 20210040206 - POIRIER; Nicolas ;   et al. | 2021-02-11 |
Non-antagonistic Antibodies Directed Against The Alpha Chain Of The Il7 Receptor Extracellular Domain And Use Thereof In Cancer Treatment App 20200308288 - POIRIER; Nicolas ;   et al. | 2020-10-01 |
Recombinant monovalent antibodies Grant 10,689,444 - Vanhove , et al. | 2020-06-23 |
NEW USES OF ANTI-SIRPg ANTIBODIES App 20190382483 - POIRIER; NICOLAS ;   et al. | 2019-12-19 |
Antibodies Directed Against CD127 App 20190382497 - POIRIER; Nicolas ;   et al. | 2019-12-19 |
Antibodies And Polypeptides Directed Against Cd127 App 20190375844 - POIRIER; Nicolas ;   et al. | 2019-12-12 |
Antibodies directed against CD127 Grant 10,428,152 - Poirier , et al. October 1, 2 | 2019-10-01 |
Anti-CD28 humanized antibodies Grant 10,364,287 - Mary , et al. | 2019-07-30 |
NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS App 20190127477 - POIRIER; Nicolas ;   et al. | 2019-05-02 |
Recombinant Monovalent Antibodies App 20170166643 - Vanhove; Bernard ;   et al. | 2017-06-15 |
Antibodies Directed Against CD127 App 20170129959 - POIRIER; Nicolas ;   et al. | 2017-05-11 |
Anti-CD28 Humanized Antibodies App 20170114136 - Mary; Caroline ;   et al. | 2017-04-27 |
Recombinant monovalent antibodies Grant 9,587,023 - Vanhove , et al. March 7, 2 | 2017-03-07 |
Anti-CD28 humanized antibodies Grant 9,562,098 - Mary , et al. February 7, 2 | 2017-02-07 |
Antibodies directed against the alpha chain of IL7 receptor--their use for the preparation of drug candidates Grant 9,447,182 - Brouard , et al. September 20, 2 | 2016-09-20 |
Method of determining the non-propagation threshold of fatigue cracks at high frequency Grant 9,423,330 - Mary , et al. August 23, 2 | 2016-08-23 |
Method Of Determining The Non-propagation Threshold Of Fatigue Cracks At High Frequency App 20150219539 - Mary; Caroline ;   et al. | 2015-08-06 |
Anti-CD28 Humanized Antibodies App 20150071916 - Mary; Caroline ;   et al. | 2015-03-12 |
Antibodies Directed Against The Alpha Chain Of Il7 Receptor - Their Use For The Preparation Of Drug Candidates App 20140308281 - Brouard; Sophie ;   et al. | 2014-10-16 |
Anti-CD28 humanized antibodies Grant 8,785,604 - Mary , et al. July 22, 2 | 2014-07-22 |
Monovalent ligands of the human CD28 receptor Grant 8,785,138 - Vanhove , et al. July 22, 2 | 2014-07-22 |
Anti-CD28 humanized Antibodies App 20130078236 - Mary; Caroline ;   et al. | 2013-03-28 |
Monovalent Ligands Of The Human Cd28 Receptor App 20130058933 - Vanhove; Bernard ;   et al. | 2013-03-07 |
Recombinant Monovalent Antibodies App 20110313135 - Vanhove; Bernard ;   et al. | 2011-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.